Diagnostic Approach for Miliary Tuberculosis
For suspected miliary tuberculosis, begin with chest radiography to identify the characteristic miliary pattern, then proceed with sputum/bronchoscopic sampling for AFB smear, culture, and molecular testing, while simultaneously pursuing tissue biopsy (liver, bone marrow, or transbronchial) for histopathologic confirmation when respiratory specimens are negative or unavailable. 1
Initial Clinical Assessment
Key Clinical Features to Identify
- Constitutional symptoms: Fever (present in 100% of cases), night sweats, anorexia (85%), weight loss (66%), and fatigue (91%) 2
- Fever pattern analysis: Look specifically for morning temperature spikes, which are characteristic of miliary TB and help distinguish it from other causes of fever of unknown origin 3
- Physical examination findings: Hepatomegaly (20%), splenomegaly (19%), and mental status changes (important prognostic indicator) 2
- Fundoscopic examination: Search for choroid tubercles (present in 8% of cases), as their presence is pathognomonic of miliary TB 2, 4, 5
Risk Factor Assessment
- Identify immunocompromising conditions: HIV infection (CD4 <100 cells/μL requires highest priority), immunosuppressive medications, liver cirrhosis, and other underlying diseases (present in 41% of cases) 1, 2
- Note that only 10-20% of patients have a history of prior TB, so absence of TB history should not exclude the diagnosis 3
Diagnostic Testing Algorithm
Step 1: Imaging Studies
- Chest radiography: Miliary pattern is present in 88% of cases, though absence does not exclude diagnosis 2
- High-resolution chest CT: Enhances detection of miliary pattern, particularly valuable when chest X-ray is normal or in immunocompromised patients 3, 4
Step 2: Respiratory Specimen Collection
- Induced sputum: Initial non-invasive approach for AFB smear (positive in 41% overall), mycobacterial culture (positive in 51%), and molecular testing 2
- Tuberculin skin testing: Limited diagnostic value (positive in only 29% of cases), but helps establish infection status; use 5mm cutoff for immunocompromised patients 1, 2
Step 3: Bronchoscopic Sampling (When Sputum Negative/Unavailable)
The ATS/IDSA/CDC guidelines recommend flexible bronchoscopy for suspected miliary TB when induced sputum is AFB smear-negative or cannot be obtained and no alternative accessible lesions exist for sampling. 1
- Preferred bronchoscopic techniques: Bronchial brushings (27-78% yield) and/or transbronchial biopsy (32-75% yield) 1
- Avoid: Bronchial washings alone (only 14% yield) 1
- Transbronchial biopsy is necessary when rapid presumptive diagnosis is critical (i.e., severely ill patients who cannot wait for culture results) 1
- Post-bronchoscopy sputum collection: Mandatory for all patients undergoing bronchoscopy (AFB smear yield 9-73%, culture yield 35-71%, up to 80% in HIV-infected patients) 1
Step 4: Tissue Biopsy for Histopathologic Confirmation
When respiratory specimens are negative or diagnosis remains uncertain:
- Liver biopsy: Highest yield with granulomas present in 100% of biopsied cases 2
- Bone marrow biopsy: Granulomas present in 82% of cases; preferred as less invasive with low complication rates 2, 4
- Transbronchial biopsy: Use when liver and bone marrow biopsies are negative 3, 4
Step 5: Microbiological Testing
- Blood cultures: Positive in 20% of cases—underutilized but valuable 2
- Mycobacterial culture: Mandatory on both liquid and solid media for species identification and drug susceptibility testing, despite low sensitivity (16.3% in some specimens) 6
- Molecular testing (GeneXpert MTB/RIF): Provides rapid results (1-2 days) with simultaneous rifampin resistance detection; particularly important in immunocompromised patients 6, 4, 5
Step 6: Extrapulmonary Evaluation
- Comprehensive organ system assessment: All patients require evaluation for concurrent organ involvement 6
- CSF analysis: If neurological symptoms present (TB meningitis has therapeutic significance requiring early identification) 4, 5
- Body fluid analysis: Cell counts and chemistries on pleural, cerebrospinal, ascitic, and joint fluids when clinically indicated 1
Critical Pitfalls to Avoid
- Do not rely on tuberculin skin testing: Positive in only 29% of miliary TB cases; anergy is common in immunosuppressed states 1, 2
- Do not wait for culture results in severely ill patients: Empiric therapy may be warranted based on reasonable clinical suspicion, as miliary TB is uniformly fatal if untreated 1, 4, 5
- Do not overlook morning temperature spikes: This fever pattern is highly characteristic and associated with only miliary TB, typhoid fever, or periarteritis nodosa 3
- Do not skip fundoscopic examination: Choroid tubercles are pathognomonic when present 2, 4, 5
Prognostic Indicators
Poor prognostic factors include: advanced age, low serum albumin, absence of miliary pattern on imaging, presence of mental status changes, low hemoglobin concentration, and development of ARDS (17% mortality rate overall, higher with ARDS) 2, 7